You are here » Home » Companies » Company Overview » Rallis India Ltd

Rallis India Ltd.

BSE: 500355 Sector: Agri and agri inputs
NSE: RALLIS ISIN Code: INE613A01020
BSE 00:00 | 28 Feb 223.70 -6.10
(-2.65%)
OPEN

225.90

HIGH

227.70

LOW

212.80

NSE 00:00 | 28 Feb 223.95 -6.15
(-2.67%)
OPEN

225.00

HIGH

227.80

LOW

212.50

OPEN 225.90
PREVIOUS CLOSE 229.80
VOLUME 55840
52-Week high 255.60
52-Week low 139.10
P/E 30.60
Mkt Cap.(Rs cr) 4,351
Buy Price 223.70
Buy Qty 48.00
Sell Price 223.70
Sell Qty 2.00
OPEN 225.90
CLOSE 229.80
VOLUME 55840
52-Week high 255.60
52-Week low 139.10
P/E 30.60
Mkt Cap.(Rs cr) 4,351
Buy Price 223.70
Buy Qty 48.00
Sell Price 223.70
Sell Qty 2.00

Rallis India Ltd. (RALLIS) - Company History

Rallis India Ltd was incorporated in the year August 23rd 1948. Rallis India the successor of Rallis Brothers and a member of Tata Group is engaged in the business of manufacture and marketing of Agri Inputs. From a solo play on agrochemicals the company has come a long way to make its presence felt across the value chain of agriculture inputs - right from seeds to organic plant growth nutrients along with a suite of package of practices and services.The company's Agribusiness division is the distributor of Pesticides fertilisers micronutrients seeds animal feed and other agro inputs. Rallis India has four production facilities of which two are located in Gujarat (at Ankleshwar and Dahej) and two in Maharashtra (at Lote and Akola). All its plants are state-of-art and meet all prescribed norms. The company discontinued marketing of Monsanto seeds during the year 2001-02. The company commenced production of a range of ethylene oxide condensates based surfactants which found captive use in its agrochemical formulations during 1999-2000. This helped the company to reduce the cost. During 2000-2001 the company established seed processing facilities at Dhar (MP) and Patancheru near Hyderabad and research infrastructure quality control and storage facility at Patancheru.The Rallis Agro Research Centre based in Bangalore leads in toxicology and entomology research. Its facilities and research practices (GLP) are recognised by Bundesgesundheitsammt (BGA) Germany.The Fine Chemicals division of the company operates two factories both in Tamilnadu at Ootacamund and Cuddalore. The company has suspended the manufacturing activity at Cuddalore plant as the third party manufacturing offers a cheaper alternative. Rallis is the leading producer and distributor of agro-based tanning materials from a variety of forest products. During 2004 the company sold out its Gelatin business of the Fine Chemicals Division to Sterling Biotech Ltd.Rallis is undertaking restructuring of its business which includes consolidation merger and selloff. First step in this regard was taken by Rallis is merger of its 5 subsidiaries viz Ralchem LtdRallis Finance & Investments Co Ltd Rallis Hybrid Seeds Ltd Rallis Farm Management Services Ltd and Sankhya Garments Ltd with itself. The petitions has been filed and the company awaiting final hearing by the court. It has also filed a petition for merging sixth subsidiary viz. Siris India Ltd with itself. During 2003-04 the Company received the approval from the court for the merger of six subsidiaries with itself.The Pharmaceutical business of Rallis which engaged in marketing of household remedies and manufacturing of basic drugs was sold to Shreya Life Sciences Pvt Ltd. a member of Russia based pharma marketing and distribution company for Rs.49 Crore. And the transfer of business is completed effective June 30 2001. The company has also completed the sale of its Andheri property to Orchid Print India Ltd. a wholly owned subsidiary of Tata Sons Ltd during the year 2001-02. Rallis has discontinued the distribution of bulk fertilizers and the arrangement with Tata Chemicals came to an end from 1st March 2003. It is also shifting its focus from a seeds distributor to become a sourcing and branding company with focussed R&D.During 2005 the company transferred its Knowledge Services Business which includes the Research & Development Centre at Bangaloreas a going concern to Advinus Therapeutics Pvt Ltd with effect from 1st April 2005 for a consideration of Rs.26 Crores.In the year 2005 the company increased its installed capacity of Pesticides (Solids) by 920 Tonnes. With this expansion the total installed capacity of Pesticides (Solids) has increased upto 22825 Tonnes.In 2006 the company has been established new Development Center at Patancheru. All Research and development including NMITLI and NPDL is being carried out at this new location. All the regulatory studies required for obtaining the registrations are being outsoured through Advinus Therapeutics Pvt Ltd and other government and private institutions.The company has started the sourcing and markeitng of Bt Cotton Seeds. An Alliance with Nuziveedu Seed Company a Major Player in hybrid and Bt Cotton seed market has been estahlished for purposes.In 2007 The company has incorporated a subsidiary in Australia viz. Rallis Australasia Pty Ltd. in order to enhance its presence in Australia.The company has successfully launched three new products in the year viz. Nova Applaud and Taqat. Applaud has been a great success in the year wherein the company gained a phenomenal response from paddy growers.The first year of Bt cottonseed marketing has been rewarding and valuable experience gained which will support expansion of this activity in the coming year. Preparation to expand into marketing of seeds in the rice and vegetable markets has been initiated.During the year 2014 Rallis India acquired additional stake of equity shares in Zero Waste Agro Organics Limited (ZWAOL) a subsidiary company of Rallis India pursuant to the Share Subscription and Share Purchase Agreement dated 23rd April 2012. Consequently the shareholding of the Company in ZWAOL has increased from 22.81% to 51.02%. During the year the Company has also acquired additional stake of equity shares in Metahelix Life Sciences Ltd. (Metahelix) pursuant to the Share Purchase Agreement dated 9 December 2010. Consequently the shareholding of the Company in Metahelix has increased from 77.02% to 80.5%.During FY 2016 the Company acquired the balance equity shares in Metahelix Life Sciences Ltd. (Metahelix). Consequently the shareholding of the Company in Metahelix has increased from 80.51% to 100% making Metahelix a wholly owned subsidiary of the Company. The company has made an investment of Rs 73.33 crores for acquiring an additional 20953 Equity Shares of Metahelix.In FY16 the Company signed an Agreement with Ikea India Pvt. Ltd. for assignment of its leasehold rights in respect of its leasehold land at Turbhe Navi Mumbai for a gross consideration of Rs 214 crores. The arrangement is subject to the Company obtaining necessary approvals under various regulations.During the year 2016 the Company's Board approved granting of a Corporate Guarantee in respect of credit facilities of up to Rs 270 crores availed by Advinus Therapeutics Ltd. (Advinus) to the extent of 16.89% of the total obligations of Advinus under such borrowings. The Guarantee has been issued during the first week of April 2016.During FY 2017 Metahelix has invested USD 122500 for 122500 Equity shares of USD 1 each with 65.77% shareholding in an Indonesian Joint Venture (JV). Mr. Suresh Vaswani the JV partner has invested his share of USD 127500 for 63750 Equity Shares of USD 2 each with 34.23% shareholding. The JV Company PT Metahelix Lifesciences Indonesia has initiated seed production operations in March 2017. Testing and evaluation of new products in Maize and Rice in Indonesia shall be initiated during 2017-18.During the year 2017 the Company has acquired the balance Equity Shares in Zero Waste Agro Organics Ltd. (ZWAOL). Consequently the shareholding of the Company in ZWAOL has increased from 73.63% to 100% making it a wholly owned subsidiary of the Company. The Company has made an investment of Rs. 19.49 crores for acquiring an additional 19421 Equity Shares of ZWAOL.During the year 2018 Metahelix has invested USD 183750 for 183750 Equity shares of USD 1 each with 65.77% shareholding in its Indonesian Joint Venture (JV) Company PT Metahelix Lifesciences Indonesia (PT Metahelix) as per the commitment in the JV Agreement. The JV partner has also invested his share of USD 191250 for 95625 Equity Shares of USD 2 each with 34.23% shareholding. The total equity of PT Metahelix stands at USD 625000 as on 31 March 2018.In FY 2017-18 the Company received four registrations for the domestic market (two each for domestic and export category) and 12 registrations for the international market. Moreover the Company has completed field trials of three more products and is ready for the registration process.During year under review the Company has gained 11 new registrations in strategic overseas markets. Partnership models with strategic customers that were adopted during the year helped the Company in its growth journey through leveraging each other's strengths. IBD continues its focus on developmental activities in key geographies in Latin America South East Asia Europe and African markets.During the year under review 3 Blocks (Afzalpur Bijapur and Bhalki) from 3 Districts (Gulbarga Bijapur and Bidar) in Karnataka were covered under PPP IAD Project with Karnataka Government for Pulses Productivity improvement for Red Gram (Pigeon Pea) and Bengal Gram (Chick Pea) which are saviour crops for farmers apart from major crops in that area. Increase in productivity and quality helps farmers for additional income generation and fetching better prices for their produce.During the year 2019 the Board of Directors of the Company approved the proposal for the merger of Metahelix a wholly owned subsidiary of the Company with the Company and their shareholders and creditors pursuant to Sections 230 to 232 of the Act and as per the terms and conditions mentioned in the Scheme of Amalgamation. The merger is subject to the necessary approvals/ sanctions from the jurisdictional National Company Law Tribunal or such other competent authority and shareholders and creditors of Metahelix and the Company as applicable.During the year 2019 the Company has made an investment of Rs 19.60 lakhs in Rallis Chemistry Exports Limited wholly owned subsidiary of the Company by way of equity shares.